Ardea Sued Over $1.3B AstraZeneca Deal
AstraZeneca PLC and Ardea Biosciences Inc. were hit with a lawsuit Monday by a proposed class of Ardea investors claiming that the British pharmaceutical giant's $1.3 billion purchase price for California-based...To view the full article, register now.
Already a subscriber? Click here to view full article